Article Link: FDA Approves The ACTpen for Actemra, A Single-Dose, Prefilled Autoinjector South San Francisco, CA — November 26, 201...
FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia
Article Link: FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia November 21, 2018 — The U.S. Food and Drug...
Genentech Announces FDA Grants Venclexta Accelerated Approval for People With Newly-Diagnosed Acute Myeloid Leukemia or Those Who Are Ineligible For Intensive Induction Chemotherapy
Article Link: Genentech Announces FDA Grants Venclexta Accelerated Approval for People With Newly-Diagnosed Acute Myeloid Leukemia or Those Who Are In...
FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis
Article Link: FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis November 20, 2018 — The U.S. F...
FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
Article Link: FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea November 16, 2018 — The U.S. Food and Drug Administrati...
FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
Article Link: FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic La...
FDA Approves Promacta (eltrombopag) for First-Line Severe Aplastic Anemia
Article Link: FDA Approves Promacta (eltrombopag) for First-Line Severe Aplastic Anemia Basel, November 16, 2018 – Novartis announc...
FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)
Article Link: FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) November 09, 2018 — Today, the U....
FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
Article Link: FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated...
FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma
Article Link: FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma RANCHO CUCAMONGA, Calif., Nov. 07, 2018...
